LAG3 anticorps (AA 70-99)
-
- Antigène Voir toutes LAG3 Anticorps
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
Épitope
- AA 70-99
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp LAG3 est non-conjugé
-
Application
- Immunocytochemistry (ICC), Functional Studies (Func)
- Specificité
- Recognizes the 30 aa extra-loop of the first N-terminal D1 domain of human LAG-3.
- Purification
- Protein A purified from tissue culture supernatant
- Immunogène
-
Synthetic peptide corresponding to 30 aa (GPPAAAPGHPLAPGPHPAAPSSWGPRPRRY) from the first N-terminal D1 domain of human LAG-3 (lymphocyte activation gene-3). Percent identity by BLAST analysis: Human (100%), Gorilla (93%), Gibbon (90%), Monkey (83%).
Type of Immunogen: Synthetic peptide - Clone
- 17B4
- Isotype
- IgG1
- Top Product
- Discover our top product LAG3 Anticorps primaire
-
-
- Indications d'application
-
Approved: Func, ICC
Usage: Functional Application - Inhibition. Immunohistochemistry - Frozen sections (1:150. Immunoprecipitation - 10 μg/mL. Western Blot - 5 μg/mL. - Commentaires
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- PBS, 0.02 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid freeze-thaw cycles.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
-
- Antigène
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
- Autre désignation
- LAG3 (LAG3 Produits)
- Synonymes
- anticorps CD223, anticorps LAG-3, anticorps Ly66, anticorps lymphocyte activating 3, anticorps lymphocyte-activation gene 3, anticorps LAG3, anticorps Lag3
- Sujet
-
Name/Gene ID: LAG3
Synonyms: LAG3, CD223 antigen, LAG-3, Protein FDC, CD223, FDC, Lymphocyte-activation gene 3 - ID gène
- 3902
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
-